| ACC 857 | NT-27a | rat | hepatocellular tumor |
| ACC 856 | N1E-115-1 | murine (mouse) | neuroblastoma |
| ACC 855 | MUG-MEL2 | human | melanoma |
| ACC 854 | HEK293-DR-GFP-XRCC3-5/X3+ | human | embryonal kidney |
| ACC 853 | HEK293-DR-GFP-XRCC2-13/X2+ | human | embryonal kidney |
| ACC 852 | HEK293-DR-GFP-RAD51D-16/D+ | human | embryonal kidney |
| ACC 851 | HEK293-DR-GFP-RAD51C-2/C+ | human | embryonal kidney |
| ACC 850 | HEK293-DR-GFP-RAD51B-9/B+ | human | embryonal kidney |
| ACC 849 | HEK293-DR-GFP-XRCC3-5 | human | embryonal kidney |
| ACC 848 | HEK293-DR-GFP-XRCC2-13 | human | embryonal kidney |
| ACC 847 | HEK293-DR-GFP-RAD51D-16 | human | embryonal kidney |
| ACC 846 | HEK293-DR-GFP-RAD51C-2 | human | embryonal kidney |
| ACC 845 | HEK293-DR-GFP-RAD51B-9 | human | embryonal kidney |
| ACC 844 | HEK293-DR-GFP | human | embryonal kidney |
| ACC 843 | CL-52b | rat | hepatocellular carcinoma |
| ACC 842 | U2OS#18-XRCC3-6A/X3+ | human | osteosarcoma |
| ACC 841 | U2OS#18-XRCC2-5E/X2+ | human | osteosarcoma |
| ACC 840 | U2OS#18-RAD51D-4/D+ | human | osteosarcoma |
| ACC 839 | U2OS#18-RAD51C-15/C+ | human | osteosarcoma |
| ACC 838 | U2OS#18-RAD51B-8/B+ | human | osteosarcoma |
| ACC 837 | U2OS#18-XRCC3-6A | human | osteosarcoma |
| ACC 836 | U2OS#18-XRCC2-5E | human | osteosarcoma |
| ACC 835 | U2OS#18-RAD51D-4 | human | osteosarcoma |
| ACC 834 | U2OS#18-RAD51C-15 | human | osteosarcoma |
| ACC 833 | U2OS#18-RAD51B-8 | human | osteosarcoma |
| ACC 832 | U2OS#18 | human | osteosarcoma |
| ACC 831 | EL-4 | mouse | lymphoma |
| ACC 830 | CHP-100 | human | neuroepithelioma |
